Physician profile

Steven Michael Topper

Hand Surgery · Colorado Springs, CO

NPI 1164411377

$158,450.75

in general payments reported to CMS, 2019-2025

7 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$143.40

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Arthrex, INC. $158,099.13 2019-2020
Aesculap, INC. $157.88 2021
Smith+Nephew, INC. $109.08 2023 Aetos Shoulder System
Depuy Synthes Sales INC. $30.34 2019
Inspire Medical Systems, INC. $21.92 2024 Inspire
Akcea Therapeutics, INC. $20.00 2020
Sirtex Medical INC $12.40 2024 Lava Les (Liquid Embolic System)

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Steven Michael Topper

$158,450.75

in general payments reported 2019-2025

Years
2019-2024
Top company
Arthrex, INC.

https://glasscript.com/doctor/279799/steven-michael-topper

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.